Using dye to predict vision after tumor surgery
Treatments studied
Part of Bones, joints & muscles, Cancer clinical trials.
This study looks at whether a special dye used during surgery can help predict how well your vision will recover after the procedure. It may help doctors better understand the results of surgery for tumors above the pituitary gland.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a tumor in the area above the pituitary gland, such as a meningioma, craniopharyngioma, or pituitary adenoma.
- You are scheduled to have surgery through the nose to remove the tumor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a special imaging dye (indocyanine green) that helps surgeons see blood flow in reconstructed tissue during head and neck surgery. The goal is to see if using this dye helps surgeons make better decisions about whether the reconstructed tissue will survive and heal properly.
This trial tests a device (CCeLL-In Vivo) that may help surgeons tell tumor from normal brain tissue during an operation, which could improve how much tumor is removed while protecting healthy brain.
This trial tests if a special dye called indocyanine green can help surgeons find sentinel lymph nodes during surgery for esophageal cancer. It may help doctors know which lymph nodes to remove for better staging.
This trial tests a special dye called indocyanine green to help surgeons see blood flow during surgery to remove part of the colon. If you have colorectal disease and need surgery, this could help make your operation safer.
This early (Phase 1) study tests whether a glowing dye called indocyanine green helps surgeons better see nervous system tumor tissue during an operation, with the goal of lowering the chance of tumor coming back locally. It’s for adults whose tumor is expected to be removable and at risk for local recurrence.
This trial tests whether a special dye called ICG, which glows under infrared light, can help surgeons better see and remove bone and soft tissue tumors during surgery. The goal is to make the removal more precise and safe.
Hear when a new Indocyanine Green trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.